BiomX Inc. (PHGE) Financials

PHGE Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 33.1 million 24.9 million
June 30, 2023 41.3 million 25.4 million
March 31, 2023 41.4 million 25.3 million
Dec. 31, 2022 45.5 million 24.5 million

PHGE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -6.0 million 195000
June 30, 2023 -4.1 million 271000
March 31, 2023 -5.1 million 175000
Dec. 31, 2022 -7.2 million 367000

PHGE Net Income

No data available :(

PHGE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 22.5 million - 3.8 million
June 30, 2023 29.7 million - 4.1 million
March 31, 2023 29.3 million - 4.3 million
Dec. 31, 2022 33.3 million - 4.5 million

PHGE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 60.6 million
June 30, 2023 51.6 million
March 31, 2023 32.1 million
Dec. 31, 2022 29.9 million

PHGE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 32000 5.6 million 2.2 million -
June 30, 2023 1000 3.8 million 2.3 million -
March 31, 2023 10000 4.6 million 1.6 million -
Dec. 31, 2022 32000 3.2 million 2.0 million -

PHGE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 -89000 219000
June 30, 2023 -90000 217000
March 31, 2023 -91000 223000
Dec. 31, 2022 -134000 624000

PHGE

Price: $0.72

52 week price:
0.36
14.71

Earnings Per Share: -37.05 USD

P/E Ratio: -0.18

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 145100

Market Capitalization: 1.2 million

Links: